RVTY vs. ABT

Last updated Apr 1, 2026

Compare and contrast key facts about Revvity Inc. (RVTY) and Abbott Laboratories (ABT).

Performance

RVTY vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revvity Inc. (RVTY) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

RVTY vs. ABT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RVTY Revvity Inc.	-9.39%	-13.07%	2.37%	-21.87%	-30.13%	40.37%	48.20%	24.01%	7.80%	40.99%
ABT Abbott Laboratories	-17.64%	12.87%	4.81%	2.26%	-20.68%	30.53%	28.04%	22.08%	29.06%	52.03%

Fundamentals

Market Cap RVTY : $9.92B ABT : $179.36B
EPS RVTY : $2.08 ABT : $3.73
PE Ratio RVTY : 42.11 ABT : 27.52
PS Ratio RVTY : 3.56 ABT : 4.05
PB Ratio RVTY : 1.37 ABT : 3.44
Total Revenue (TTM) RVTY : $2.86B ABT : $44.33B
Gross Profit (TTM) RVTY : $1.52B ABT : $24.61B
EBITDA (TTM) RVTY : $643.66M ABT : $11.33B

Returns By Period

In the year-to-date period, RVTY achieves a -9.39% return, which is significantly higher than ABT's -17.64% return. Over the past 10 years, RVTY has underperformed ABT with an annualized return of 6.03%, while ABT has yielded a comparatively higher 11.37% annualized return.

RVTY

• 1D: 3.34%
• 1M: -10.88%
• YTD: -9.39%
• 6M: 0.09%
• 1Y: -16.96%
• 3Y*: -12.82%
• 5Y*: -7.36%
• 10Y*: 6.03%

ABT

• 1D: 0.78%
• 1M: -11.76%
• YTD: -17.64%
• 6M: -22.62%
• 1Y: -21.15%
• 3Y*: 2.45%
• 5Y*: -1.11%
• 10Y*: 11.37%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RVTY vs. ABT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVTY

RVTY Risk / Return Rank: 22
RVTY Sharpe Ratio Rank: 22
RVTY Sortino Ratio Rank: 22
RVTY Omega Ratio Rank: 23
RVTY Calmar Ratio Rank: 22
RVTY Martin Ratio Rank: 19

ABT

ABT Risk / Return Rank: 8
ABT Sharpe Ratio Rank: 6
ABT Sortino Ratio Rank: 10
ABT Omega Ratio Rank: 9
ABT Calmar Ratio Rank: 13
ABT Martin Ratio Rank: 2

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVTY vs. ABT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revvity Inc. (RVTY) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RVTY	ABT	Difference
Sharpe ratio Return per unit of total volatility	-0.43	-0.92	+0.49
Sortino ratio Return per unit of downside risk	-0.37	-1.12	+0.75
Omega ratio Gain probability vs. loss probability	0.96	0.84	+0.12
Calmar ratio Return relative to maximum drawdown	-0.59	-0.80	+0.21
Martin ratio Return relative to average drawdown	-1.19	-2.02	+0.83
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RVTY vs. ABT - Sharpe Ratio Comparison

The current RVTY Sharpe Ratio is -0.43, which is higher than the ABT Sharpe Ratio of -0.92. The chart below compares the historical Sharpe Ratios of RVTY and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RVTY	ABT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.43	-0.92	+0.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.22	-0.05	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.20	0.48	-0.28
Sharpe Ratio (All Time) Calculated using the full available price history	0.22	0.41	-0.19

Correlation

The correlation between RVTY and ABT is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

RVTY vs. ABT - Dividend Comparison

RVTY's dividend yield for the trailing twelve months is around 0.32%, less than ABT's 2.34% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RVTY Revvity Inc.	0.32%	0.29%	0.25%	0.26%	0.20%	0.14%	0.20%	0.29%	0.36%	0.48%	0.54%	0.52%
ABT Abbott Laboratories	2.34%	1.88%	1.95%	1.85%	1.71%	1.28%	1.32%	1.47%	1.55%	1.86%	2.71%	2.14%

Drawdowns

RVTY vs. ABT - Drawdown Comparison

The maximum RVTY drawdown since its inception was -92.39%, which is greater than ABT's maximum drawdown of -55.57%. Use the drawdown chart below to compare losses from any high point for RVTY and ABT.

Drawdown Indicators

	RVTY	ABT	Difference
Max Drawdown Largest peak-to-trough decline	-92.39%	-55.57%	-36.82%
Max Drawdown (1Y) Largest decline over 1 year	-28.75%	-25.18%	-3.57%
Max Drawdown (5Y) Largest decline over 5 years	-59.01%	-33.88%	-25.13%
Max Drawdown (10Y) Largest decline over 10 years	-59.01%	-33.88%	-25.13%
Current Drawdown Current decline from peak	-55.98%	-25.41%	-30.57%
Average Drawdown Average peak-to-trough decline	-29.73%	-14.29%	-15.44%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.16%	9.94%	+4.22%

Volatility

RVTY vs. ABT - Volatility Comparison

Revvity Inc. (RVTY) has a higher volatility of 11.02% compared to Abbott Laboratories (ABT) at 5.95%. This indicates that RVTY's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RVTY	ABT	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.02%	5.95%	+5.07%
Volatility (6M) Calculated over the trailing 6-month period	25.97%	16.83%	+9.14%
Volatility (1Y) Calculated over the trailing 1-year period	40.02%	23.14%	+16.88%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.27%	21.98%	+11.29%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.32%	23.57%	+6.75%

Financials

RVTY vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between Revvity Inc. and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RVTY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Revvity Inc. reported a gross profit of 421.66M and revenue of 772.06M. Therefore, the gross margin over that period was 54.6%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a gross profit of 6.54B and revenue of 11.46B. Therefore, the gross margin over that period was 57.1%.

RVTY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Revvity Inc. reported an operating income of 96.01M and revenue of 772.06M, resulting in an operating margin of 12.4%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported an operating income of 2.25B and revenue of 11.46B, resulting in an operating margin of 19.6%.

RVTY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Revvity Inc. reported a net income of 98.36M and revenue of 772.06M, resulting in a net margin of 12.7%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a net income of 1.78B and revenue of 11.46B, resulting in a net margin of 15.5%.